Sarepta Therapeutics, Inc. — Director's Dealing 2011

Jun 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-06-20

Reporting Person: Kaye Edward M. MD (SVP & Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-20	Stock Option (right to buy)	$1.38	A	850000	Acquired	2021-06-20	Common Stock (850000)	Direct

Footnotes

F1: This option is exercisable at the rate of 25% of the shares on June 20, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on June 20, 2015.